About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 3NCT01398839

Safety Study of the VEGA UV-A System to Treat Ectasia

The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.

Lead sponsor: Topcon Medical Systems, Inc.•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Topcon Medical Systems, Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 Years of age or older
•Diagnosis of Ectasia
•Presence of central or inferior steepening
•Topography consistent with ectasia
•BSCVA 20/20 or worse
•If contact lens wearer; removal of contact lenses for required period of time
•Signed informed consent
•Willingness and ability to comply with schedule for follow-up visits

Exclusion Criteria

•Previous ocular condition that may predispose the eye for future complications or prevent the possibility of improved vision
•History of chemical injury or delayed epithelial healing
•A known sensitivity to study medications
•Nystagmus or any other condition that would prevent a steady gaze during the treatment or other diagnostic tests
•A condition that would interfere with or prolong epithelial healing
•Presence or history of any other condition or finding that makes the patient unsuitable for treatment

Related studies

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

NCT06306963 · Gastric Antral Vascular Ectasia, Cirrhosis, and more

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

NCT02118922 · Keratoconus, Ectasia, and more

RECRUITINGPhase 2

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

NCT04094090 · Keratoconus, Pellucid Marginal Corneal Degeneration, and more

Middle East Coronary Artery Ectasia Registry

NCT05213429 · Coronary Artery Ectasia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 29, 2022Terms

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment103

Start dateDec 2010

Last updatedJun 29, 2022

Condition

Locations shown

Barnet Dulaney Perkins Eye Center

Phoenix, Arizona

Woolfson Eye Institute

Atlanta, Georgia

Minnesota Eye Consultants, P.A.

Bloomington, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 29, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions